Alternatives to Bausch + Lomb
Bausch + Lomb is a MedTech tool: global eye health company offering contact lenses, lens care, supplements, and prescription pharmaceuticals. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest MedTech companies to Bausch + Lomb
- Website
Tarsier Pharma47HealthcareTel Aviv, Israel$5.0MClinical-stage company developing novel treatments for ocular inflammatory blinding diseases.
- Website
Ray Therapeutics53BiotechnologyBerkeley, USA$243.0MPioneering vision restoration therapies for severe retinal degenerations.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Fluxergy54MedTechIrvine, United States$200.0MDevelops a point-of-care diagnostic platform for rapid and accurate disease detection.
- Website
EyeGate Pharmaceuticals32BiotechWaltham, United States$45.5MClinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases.
- Website
Schrödinger69Drug DiscoveryNew York, United States$220.0MPhysics-based software platform for molecular discovery and design in life and materials sciences.
- Website
CytoReason68HealthcareTel Aviv, Israel$128.3MDevelops a computational model of the human body for drug discovery and development.
- Website
BeiGene64BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- ISISRAEL VENTURES PLUS INCUBATORS TEC MEDITECH PHARMA CONSORTIUM42MedTechTel Aviv, Israel$39.6M
A consortium focused on incubating and developing technology in the medtech and pharma sectors in Israel.
- Website
Elicit62Artificial IntelligenceOakland, United States$31.0MAI-powered research assistant for scientific literature review and data extraction.
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website
Algorithmiq60Quantum ComputingHelsinki, Finland$38.1MQuantum software company enabling breakthroughs in chemistry, materials science, and life sciences.
- Website
Adcendo60BiotechnologyCopenhagen, Denmark$272.0MDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
- Website
Atomwise60Drug DiscoverySan Francisco, United States$176.3MAtomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
Enterome60BiotechnologyParis, France$123.9MClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
- Website
CellCentric60BiotechnologyCambridge, United Kingdom$375.0MA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
- Website
Celerion59BiotechnologyLincoln, USA$45.0MA global leader in clinical pharmacology and bioanalytical sciences.
- Website
Mironid59BiotechnologyGlasgow, United Kingdom$46.0MBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
- Website
Ethypharm58PharmaceuticalsSaint-Cloud, France$557KInternational specialty pharmaceutical company focused on central nervous system, pain management, and addiction treatments.
Showing the 20 closest matches. See the rest on the Bausch + Lomb profile.
Compare Bausch + Lomb head to head
Side by side on what each one does, what it costs, and what real users report.